Skip to Main Content
  • Professor of Medicine; Director, Yale Center for Pancreatic Diseases

    Dr James Farrell is an internationally recognized expert in pancreatic disease treatment and research. In addition to his clinical work on the endoscopic evaluation of autoimmune pancreatitis and pancreatic cysts, he is also known for his development of personalized therapy approaches for pancreatic cancer and early detection biomarkers for pancreatic cancer.

    Dr Farrell received his medical degree from University College Dublin. He completed internal medicine training at the Johns Hopkins Hospital and Johns Hopkins University, in Baltimore and a Gastroenterology Fellowship at the Massachusetts General Hospital and Harvard Medical School in Boston. He subsequently pursued additional advanced therapeutic endoscopic fellowship training at the Massachusetts General Hospital and the Brigham and Women’s Hospital in Boston. After fellowship, he was recruited to UCLA Medical Center in Los Angeles where he developed the largest endoscopic ultrasound program in California and became a founding member of the UCLA Center for Pancreatic Diseases. In 2013 he was recruited to lead the Yale Center for Pancreatic Diseases at Yale School of Medicine and the Yale New Haven Hospital, while also joining the existing Yale Interventional Endoscopy Program.

    In addition to his clinical practice in pancreatic disease and interventional endoscopy, his clinical research has focused on early detection of pancreatic cancer including studying pancreatitis, high risk individuals (e.g. inherited mutations, family history) and pancreatic cysts. His translational research includes the development of personalized therapy approaches for pancreatic cancer and the evaluation of biomarkers in pancreatic disease.

    Dr Farrell is board certified in Internal Medicine, Gastroenterology and Clinical Pharmacology. He is the author of numerous publications, is invited to speak nationally and internationally, and maintains a vigorous clinical practice focused on all aspects of interventional endoscopy, gastrointestinal cancer, and pancreatic diseases. He currently serves on the medical advisory board for PANCAN, the Pancreas Cancer Action Network, as well as the NIH/NCI Pancreas Cancer Task Force.

  • Professor of Medicine; Associate CEHE Director for Cancer Screening, Smilow Cancer Hospital; Medical Director, Cancer Screening and Prevention Program, and Colorectal Cancer Prevention Program; Co-Director, Cancer Genetics and Prevention Program

    After obtaining his MD degree from the Autonomous University Barcelona, Dr. Llor trained in basic research and Internal Medicine at the University of Chicago and completed his GI fellowship at the University of Illinois at Chicago. He complemented his training with a PhD degree in molecular biology from the University of Barcelona. A clinically active gastroenterologist, Dr. Llor’s research and clinical interests relate to colorectal cancer. He has a very active basic and translational research program mainly focusing on two different aspects of colorectal cancer: hereditary and familial forms, and disparities in colorectal cancer. This work has resulted in almost 100 scientific publications in this field. He has made seminal contributions to the field of Lynch syndrome diagnosis as well as in the definition of other non-polyposis syndromic colorectal cancer cases. Some of his most recent work is providing important clues to the understanding of the biological differences that contribute to disparities in colorectal cancer. Watch a video with Dr. Xavier Llor >>

    Dr. Llor is the Director of the Smilow Cancer Genetics and Prevention Program; Associate Director for Cancer Screening, Community Engagement and Health Equity (CEHE);  and Medical Director of the Colorectal Cancer Prevention Program at Yale University and Smilow Cancer Hospital and he sees patients at Yale. He is a member of the steering committee of the National Colorectal Cancer Round Table (NCCRT) and member of the National Comprehensive Cancer Network (NCCN) guidelines panels for colorectal cancer screening and colorectal cancer genetics. He is commonly invited to lecture in colorectal cancer genetics in the US and abroad.

  • Lead Genetic Counselor

    Amanda Ganzak is one of the Lead Genetic Counselors for the Smilow Cancer Genetics and Prevention Program. Amanda graduated from the genetic counseling program at Arcadia University. She previously worked as a cancer genetic counselor at MD Anderson Cancer Center in Houston, TX and the Hospital of the University of Pennsylvania in Philadelphia, PA before joining the Smilow Cancer Genetics and Prevention Program. Amanda provides outreach coordination for cancer genetics services through Bridgeport Hospital and Greenwich Hospital.  Amanda sees patients in our outreach location at Park Avenue Medical Center in Trumbull. She values being able to provide comprehensive, multidisciplinary care and access to genetic testing to patients within the Smilow Cancer Hospital at Yale New Haven Health system. She is also passionate about training and mentoring junior genetic counselors joining the Smilow Cancer Genetics and Prevention Program.   Amanda is a member of the National Society of Genetic Counselors (NSGC) and serves as a member of the NSGC Cancer Special Interest Group.

    Amanda sees patients in Trumbull.

     


  • Lead Genetic Counselor

    Claire Healy is one of the Lead Genetic Counselors for the Smilow Cancer Genetics and Prevention Program.  She graduated from the genetic counseling program at the University of North Carolina at Greensboro and previously worked as a genetic counselor at the Dana Farber Cancer Institute until joining the Smilow Cancer Genetics and Prevention Program. Claire is passionate about the field of hereditary cancer genetic counseling and wants to ensure that all patients have access to genetic counseling services despite their geographic location or socioeconomic status. She enjoys the collaborative and interdisciplinary team at Yale and is proud of the care patients receive in the program.  Claire is a member of the National Society of Genetic Counselors (NSGC) and serves as a member of the NSGC Cancer Special Interest Group. 

    Claire sees patients at New Haven, Waterford, Hartford, Torrington*

    *Genetic counseling services provided via telehealth at this location